"Orchiectomy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The surgical removal of one or both testicles.
| Descriptor ID |
D009919
|
| MeSH Number(s) |
E04.270.282.679 E04.950.165.679 E04.950.774.860.618
|
| Concept/Terms |
Orchiectomy- Orchiectomy
- Orchiectomies
- Orchidectomy
- Orchidectomies
Castration, Male- Castration, Male
- Castrations, Male
- Male Castration
- Male Castrations
|
Below are MeSH descriptors whose meaning is more general than "Orchiectomy".
Below are MeSH descriptors whose meaning is more specific than "Orchiectomy".
This graph shows the total number of publications written about "Orchiectomy" by people in this website by year, and whether "Orchiectomy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 1 | 3 |
| 2007 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Orchiectomy" by people in Profiles.
-
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST). J Clin Oncol. 2022 08 01; 40(22):2468-2478.
-
The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy. Urol Oncol. 2017 05; 35(5):183-191.
-
A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy. Anticancer Drugs. 2013 Aug; 24(7):743-53.
-
The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int. 2013 Sep; 112(5):548-60.
-
ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype. Carcinogenesis. 2012 Mar; 33(3):572-80.
-
Testicular lymphoma. Semin Oncol. 2010 Dec; 37(6):549-54.
-
Dissociation of genetic and hormonal influences on sex differences in alcoholism-related behaviors. J Neurosci. 2010 Jul 07; 30(27):9140-4.
-
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007 Apr 20; 25(12):1596-605.
-
Critical evaluation of hormonal therapy for carcinoma of the prostate. Urology. 2002 Aug; 60(2):201-8.
-
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. 2002 Jul 15; 95(2):361-76.